Detalles de la búsqueda
1.
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.
BMC Med
; 21(1): 388, 2023 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37814306
2.
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trial.
Diabetes Obes Metab
; 25(5): 1229-1240, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36594724
3.
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.
Diabetes Obes Metab
; 25(3): 785-795, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36433709
4.
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
Diabetologia
; 64(5): 1066-1078, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33687487
5.
The protective role of serum uric acid against premature membrane rupture in gestational diabetes: a cross-sectional study.
BMC Endocr Disord
; 21(1): 95, 2021 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957911
6.
MREG suppresses thyroid cancer cell invasion and proliferation by inhibiting Akt-mTOR signaling.
Biochem Biophys Res Commun
; 491(1): 72-78, 2017 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698135
7.
The effects of metformin on fibroblast growth factor 19, 21 and fibroblast growth factor receptor 1 in high-fat diet and streptozotocin induced diabetic rats.
Endocr J
; 64(5): 543-552, 2017 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28413172
8.
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study.
Diabetologia
; 64(8): 1900-1901, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34037812
9.
Knockdown of filaggrin influences the epidermal terminal differentiation via MAPK pathway in normal human epidermal keratinocytes.
Mol Biol Rep
; 42(2): 337-43, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25374427
10.
Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study.
J Diabetes
; 16(6): e13563, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783768
11.
Circulating asprosin concentrations in individuals with new-onset type 2 diabetes and prediabetes.
Diabetes Res Clin Pract
; 213: 111730, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38866185
12.
Treatment with acarbose in severe hypoglycaemia due to late dumping syndrome.
West Indian Med J
; 62(9): 861-3, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117397
13.
Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy.
Int J Gen Med
; 16: 4027-4037, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37700740
14.
Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
J Diabetes Complications
; 37(11): 108614, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769508
15.
Metformin Preserves Insulin Secretion in Pancreatic ß-cells through FGF21/Akt Pathway In vitro and In vivo.
Comb Chem High Throughput Screen
; 2023 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855357
16.
Pharmacokinetics, Pharmacodynamics and Safety of Janagliflozin in Chinese Type 2 Diabetes Mellitus Patients with Renal Impairment.
Clin Pharmacokinet
; 62(8): 1093-1103, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284974
17.
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity.
Nat Commun
; 14(1): 8289, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092790
18.
Metformin attenuates high glucose-induced injury in islet microvascular endothelial cells.
Bioengineered
; 13(2): 4385-4396, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139776
19.
X-box binding protein 1: A new metabolic mediator and drug target of metformin?
Front Pharmacol
; 13: 1013218, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36438823
20.
Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: a meta-analysis.
Arch Endocrinol Metab
; 66(2): 157-167, 2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35289514